RAP 0.00% 20.5¢ resapp health limited

Pfizer have dangled peanuts, some RAP shareholders short sighted monkeys., page-22

  1. 26,643 Posts.
    lightbulb Created with Sketch. 1729
    ResAppDx revenue has just started, if they are "gas" out then time for new management. No spin, the technology hasn't changed since you've invested in RAP many years ago. Their core products are still acute respiratory diagnosis and chronic respiratory management.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.